Regenerative Medicine Market to Reach $5.5 Billion by 2025: Increased Prevalence of Neurodegenerative, Orthopedic & Other Aging-related Disorders

News provided by

Aug 21, 2017, 05:30 ET

DUBLIN, August 21, 2017 /PRNewswire/ --

The "Regenerative Medicine Market, 2014 - 2025" report has been added to Research and Markets' offering.

The global regenerative medicine market size is expected to reach USD 5.59 billion by 2025, according to this new report. Increased prevalence of neurodegenerative, orthopedic, and other aging-related disorders in geriatric population coupled with rising global geriatric population is anticipated to drive market growth.

Developments in biotechnology have enabled gaining in-depth knowledge pertaining to cell division and differentiation as well as the metabolism mechanism of various cells. This enriched knowledge, coupled with emergence of novel streams of biotechnology such as gene therapy and nanotechnology, further prospered use of cell-based technology in therapeutic treatment.

Identification of ability of stem cells to develop into various different cell lines further propelled the advancements in regenerative medicine. Frequent media exposure due to regulatory as well as ethical controversies around embryonic stem cells has increased awareness among the masses. This encouraged researchers to explore and develop other potential fields for similar applications, such as induced pluripotent stem cells (iPSC).

Furthermore, the emergence of gene therapy techniques with potential to rectify and restore effects of gene mutations in cells is under development. Conditions caused due to Single Nucleotide Polymorphism (SNP) as well as mutations that induce degenerative characteristics are primarily targeted.

Companies Mentioned

Integra LifeSciences Corporation
Astellas Pharma Inc.
Ocata Therapeutics, Inc.
Corline Biomedical AB
Cook Biotech
Bayer BV
BlueRock Therapeutics
AstraZeneca
MedImmune
F. Hoffmann-La Roche Ltd
Pfizer Inc.
Merck & Co., Inc.
Sigma-Aldrich Co. LLC
Merck Millipore
Abbott
St. Jude Medical, Inc.
Vericel Corporation
Novartis AG
Alcon
GlaxoSmithKline plc.
(15+ Others)

Key Topics Covered:

1 Research Methodology

2. Executive Summary

3. Regenerative Medicnie Market Variables, Trends & Scope

4. Regenerative Medicine Market: Product Type Estimates & Trend Analysis

5. Regenerative Medicine Market: Therapeutic Category Estimates & Trend Analysis

6. Regenerative Medicine Market: Regional Estimates & Trend Analysis, by Product And Therapeutic Category

7. Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/research/948x9s/regenerative

Media Contact:

Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets